Skip to main content

Table 1 Socio-demographic characters, anthropometric measurements, and basic lab findings among the studied groups

From: Real-time elastography “FibroScan” compared to simple non-invasive screening tools in the assessment of liver fibrosis in non-alcoholic fatty liver patients

Variable Group I (n = 100) Group II (n = 30) P
Age (years), mean ± SD 47.1 ± 11.6 43.1 ± 9.9 0.086 0.086 (NS)
Sex    0.083 (NS)
 Male 60 (60%) 15 (50%)  
 Female 40 (40%) 15 (50%)  
DM    0.001 (HS)
 Non-diabetic 71 (71%) 30 (100%)  
 Diabetic 29 (29%) 0 (0%)  
Weight (kg) 94.09 ± 17.0 75.0 ± 13.22  < 0.01(HS)
Height (cm) 167.6 ± 6.16 169.1 ± 6.72 0.253(NS)
BMI (kg/m2) 33.4 ± 5.34 26.1 ± 3.62  < 0.01(HS)
Total cholesterol (mg/dl) 236.0 ± 17.7 123.1 ± 16.6  < 0.001(HS)
HDL cholesterol 58.5 ± 8.33 86.2 ± 9.44  < 0.001(HS)
LDL cholesterol 139.5 ± 9.71 82.1 ± 11.72  < 0.001(HS)
TG (mg/dl) 161.0 ± 18.38 99.2 ± 6.82  < 0.001(HS)
AST 35.8 ± 29.4 20.0 ± 5.8  < 0.001(HS)
ALT 39.7 ± 29.8 19.1 ± 7.3  < 0.001(HS)
T. bilirubin (mg/dl) 0.72 ± 0.17 0.86 ± 0.09  < 0.031(S)
Albumin (g/dl) 4.15 ± 0.36 4.55 ± 0.43  < 0.022(S)
INR 1.00 ± 0.01 1.00 ± 0.00 1.0 (NS)
Creatinine (mg/dl) 0.90 ± 0.15 0.91 ± 0.07 0.839 (NS)
Hemoglobin (mg/dl) 13.1 ± 1.85 12.9 ± 1.52 0.48 (NS)
WBCs (cell/mm3) 7171.4 ± 2043.91 6302.5 ± 1283.16 0.038 (S)
PLTs (× 103/mm3) 241.1 ± 74.77 241.9 ± 50.90 0.76 (NS)